red vine leaf extract
Botanicalexperimental
Clinical trial activity
7 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
5
Phase 3
3
Phase 4
1
Earliest trial started Apr 1, 1998 (NCT02191280)
Timeline
Indications
Approved for
Mechanism of action
- Unspecified targetSupplementation
supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- read vine leaf extract
- red vine leaf extract
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00855179 | Phase 3 | Mar 1, 2009 | Boehringer Ingelheim |
| NCT00292435 | Phase 3 | Mar 1, 2006 | Boehringer Ingelheim |
| NCT02191254 | Phase 3 | Apr 1, 2004 | Boehringer Ingelheim |
| NCT02191163 | Phase 2 | Apr 1, 2002 | Boehringer Ingelheim |
| NCT02191241 | Phase 1 | Aug 1, 2001 | Boehringer Ingelheim |
| NCT02184234 | Phase 4 | Jun 1, 2001 | Boehringer Ingelheim |
| NCT02191280 | Phase 2 | Apr 1, 1998 | Boehringer Ingelheim |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Boehringer Ingelheim | For profit | 7 | 7 | 4 | 1998 |
1 organizations
Page 1 / 1